Claire Coe Smith

PE firms are turning to technology in a bid to widen access to the asset class.

Collecting ESG data is just the first step on a long journey towards sustainability reporting.

PE-backed healthcare businesses can help improve patient access and outcomes, but thorough due diligence, support and oversight are needed to ensure progress is made on ESG.

Since the GFC, the industry has found itself the subject of increasing regulatory scrutiny, which has in turn helped shape the story of the asset class.

As LPs continue to focus on ESG, there are signs GPs are getting better at meeting their demands.

There may be disruption in the public markets, but tech verticals are still being primed for growth, whatever the future holds.

Falling valuations are failing to cool PE appetite for enterprise software.

Investor appetite for climate-orientated solutions is growing as a political push for action accelerates momentum.

Five levers that will be integral to driving portfolio performance over the next five years.

Volatility may have slowed the rate of dealmaking, but for GPs accustomed to investing and driving growth across cycles, the mid-market still holds plenty of opportunities.